
The aim of the trial is to determine whether the drug haloperiodol has a beneficial effect in treating critically ill patients with delirium.
Delirium is the clinical representation of a dysfunctional brain, e.g. caused by critical illness. The trial compares haloperidol with a placebo (saline).
Trial Sponsor
MD, Lone Musaeus Poulsen
Zealand University Hospital, Køge
lmp@regionsjaelland.dk

Useful Documents
Time Plan

Overview of Recruitment